Bioburden Testing Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Bioburden Testing Market Size Analysis and Top Companies

The global bioburden testing market size is projected to surpass around USD 5.07 billion by 2033 from USD 1.32 billion in 2023, expanding at a healthy CAGR of 14.40% between 2023 and 2033. The top companies in the bioburden testing market are North American Science Associates, LLC, Nelson Laboratories, LLC, Thermo Fisher Scientific Inc, Charles River Laboratories, Merck KGaA, SGS Societe Generale de Surveillance SA., WuXi AppTec, BD, BIOMÉRIEUX, Pacific Biolabs, and Others.

Market Report Coverage

Bioburden Testing Market Lead Manufacturers

• North American Science Associates, LLC
• Nelson Laboratories, LLC
• Thermo Fisher Scientific Inc
• Charles River Laboratories
• Merck KGaA
• SGS Société Générale de Surveillance SA.
• WuXi AppTec
• BD
• BIOMÉRIEUX
• Pacific Biolabs

Recent Developments

• In May 2023, Veolia's Sievers Soleil became the industry’s first comprehensive solution for microbial testing, offering near real-time detection for pharmaceutical processes to improve contamination control and process efficiency.
• In July 2022, Merck invested € 200,000 to open their first Microbiology Application and Training Lab in Bengaluru, India, enhancing microbial quality control capabilities for the pharma and biopharma industries with services like rapid bioburden testing and certified training.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344